These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27433515)

  • 1. Serological and Histological Examination of a Nonalcoholic Steatohepatitis Mouse Model Created via the Administration of Monosodium Glutamate.
    Takai A; Kikuchi K; Kajiyama Y; Sugiura A; Negishi M; Tsunashima H; Yamada H; Matsumoto K; Tsuneyama K; Moritoki Y; Hara M; Miyakawa H
    Int Sch Res Notices; 2014; 2014():725351. PubMed ID: 27433515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulated myeloid-derived suppressor cells demonstrate distinct phenotypes and functions in two non-alcoholic steatohepatitis mouse models.
    Tsunashima H; Tsuneyama K; Moritoki Y; Hara M; Kikuchi K
    Hepatobiliary Surg Nutr; 2015 Oct; 4(5):313-9. PubMed ID: 26605278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis.
    Takai A; Kikuchi K; Ichimura M; Tsuneyama K; Moritoki Y; Matsumoto K; Tsunashima H; Onda T; Kuniyoshi N; Nariyama T; Ohyatsu S; Kubota J; Nagumo K; Sato S; Hara M; Miyakawa H
    BMC Gastroenterol; 2020 Feb; 20(1):46. PubMed ID: 32103741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
    Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA
    J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
    Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.
    Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G
    J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
    Belemets N; Kobyliak N; Virchenko O; Falalyeyeva T; Olena T; Bodnar P; Savchuk O; Galenova T; Caprnda M; Rodrigo L; Skladany L; Delev D; Opatrilova R; Kruzliak P; Beregova T; Ostapchenko L
    Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T
    Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of Fas mutation on non-alcoholic steatohepatitis in mice].
    Su SS; Han F; Wang RQ; Ren WG; Wu WJ; Kong LB; Zhao SX; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):653-7. PubMed ID: 22152378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia.
    Nakanishi Y; Tsuneyama K; Fujimoto M; Salunga TL; Nomoto K; An JL; Takano Y; Iizuka S; Nagata M; Suzuki W; Shimada T; Aburada M; Nakano M; Selmi C; Gershwin ME
    J Autoimmun; 2008; 30(1-2):42-50. PubMed ID: 18178378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice.
    Chen R; Wang Q; Song S; Liu F; He B; Gao X
    Eur J Pharmacol; 2016 Jan; 770():126-33. PubMed ID: 26593434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of β-caryophyllene on nonalcoholic steatohepatitis.
    Arizuka N; Murakami T; Suzuki K
    J Toxicol Pathol; 2017 Oct; 30(4):263-273. PubMed ID: 29097836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.
    Nicholls HT; Hornick JL; Cohen DE
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G50-G61. PubMed ID: 28385694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
    Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
    Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.
    González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM
    Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.